Aiming at strategies for a complex problem of medical nonadherence

Global Heart

Volumn 8, Issue 3, 2013, Pages 263-271

  Castellano, Jose M ^a   Copeland Halperin, Robert ^a   Fuster, Valentin ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; COGNITIVE DEFECT; CONGESTIVE HEART FAILURE; DEPRESSION; DRUG USE; FEEDING BEHAVIOR; HABIT; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH LITERACY; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; INTERPERSONAL COMMUNICATION; LIFESTYLE MODIFICATION; MARRIAGE; MEDICATION COMPLIANCE; MOTIVATION; OBESITY; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SATISFACTION; PHYSICAL ACTIVITY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SMOKING; SOCIAL SUPPORT; SOCIOECONOMICS; TREATMENT REFUSAL; WEIGHT REDUCTION;

EID: 84884926151     PISSN: 22118160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gheart.2013.06.001     Document Type: Review

References (55)

1. H.B. Bosworth, B.B. Granger, and P. Mendys Medication adherence: a call for action Am Heart J 162 2011 412 424
2. B. Gottlieb Medical nonadherence: finding solutions to a costly medical problem Drug Benefit Trends 12 2000 57 62
3. S. De Geest, and E. Sabaté Adherence to long-term therapies: evidence for action Eur J Cardiovasc Nurs 2 2003 323
4. A. Gehi, D. Haas, S. Pipkin, and M.A. Whooley Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study Arch Intern Med 165 2005 2508 2513
5. V. Fuster Promoting Cardiovascular Health in the Developing World: A Critical Challenge To Achieve Global Health 2010 Institue of Medicine Washington, DC
6. V. Fuster, B.B. Kelly, and R. Vedanthan Promoting global cardiovascular health: moving forward Circulation 123 2011 1671 1678
7. P. Muntner, D. Mann, R.P. Wildman, D. Shimbo, V. Fuster, and M. Woodward Projected impact of polypill use among US adults: medication use, cardiovascular risk reduction, and side effects Am Heart J 161 2011 719 725
8. S. Yusuf, S. Islam, C.K. Chow PURE Study Investigators Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey Lancet 378 2011 1231 1243
9. J.W. Cheng, M.M. Kalis, and S. Feifer Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Pharmacotherapy 21 2001 828 841
10. G. Dailey, M.S. Kim, and J.F. Lian Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a Medicaid patient population with type 2 diabetes mellitus Clin Ther 23 2001 1311 1320
11. E.M. Holper, M.M. Brooks, L.J. Kim BARI Investigators Effects of heart failure and diabetes mellitus on long-term mortality after coronary revascularization (from the BARI Trial) Am J Cardiol 100 2007 196 202
12. L.J. Shaw, D.S. Berman, D.J. Maron COURAGE Investigators Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
13. B.L. Senst, L.E. Achusim, and R.P. Genest Practical approach to determining costs and frequency of adverse drug events in a health care network Am J Health Syst Pharm 58 2001 1126 1132
14. J.A. Johnson, and J.L. Bootman Drug-related morbidity and mortality: a cost-of-illness model Arch Intern Med 155 1995 1949 1956
15. F.R. Ernst, and A.J. Grizzle Drug-related morbidity and mortality: updating the cost-of-illness model J Am Pharm Assoc (Wash) 41 2001 192 199
16. J.R. Wu, D.K. Moser, T.A. Lennie, and P.V. Burkhart Medication adherence in patients who have heart failure: a review of the literature Nurs Clin North Am 43 2008 133 153 vii-viii
17. J. Dunbar-Jacob, J.A. Erlen, E.A. Schlenk, C.M. Ryan, S.M. Sereika, and W.M. Doswell Adherence in chronic disease Annu Rev Nurs Res 18 2000 48 90
18. A.S. Gadkari, and C.A. McHorney Medication nonfulfillment rates and reasons: narrative systematic review Curr Med Res Opin 26 2010 683 705
19. P.M. Ho, D.J. Magid, F.A. Masoudi, D.L. McClure, and J.S. Rumsfeld Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease BMC Cardiovasc Disord 6 2006 48
20. R.H. Mehta, E.D. Peterson, and R.M. Califf Performance measures have a major effect on cardiovascular outcomes: a review Am J Med 120 2007 398 402
21. G.S. Wagner, M.C. Bahit, and D. Criger Moving toward a new definition of acute myocardial infarction for the 21st century: status of the ESC/ACC consensus conference. European Society of Cardiology and American College of Cardiology J Electrocardiol 33 Suppl 2000 57 59
22. K.P. Lowry, T.K. Dudley, E.Z. Oddone, and H.B. Bosworth Intentional and unintentional nonadherence to antihypertensive medication Ann Pharmacother 39 2005 1198 1203
23. A. Bardel, M.A. Wallander, and K. Svärdsudd Factors associated with adherence to drug therapy: a population-based study Eur J Clin Pharmacol 63 2007 307 314
24. K.S. Ingersoll, and J. Cohen The impact of medication regimen factors on adherence to chronic treatment: a review of literature J Behav Med 31 2008 213 224
25. J.L. Grenard, B.A. Munjas, and J.L. Adams Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis J Gen Intern Med 26 2011 1175 1182
26. D. Hevey, H.M. McGee, and J. Horgan Relationship of initial level of distress to changes in health-related quality of life during cardiac rehabilitation or usual care Psychosom Med 69 2007 793 797
27. G. van Servellen, B. Chang, L. Garcia, and E. Lombardi Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women AIDS Patient Care STDS 16 2002 269 281
28. W. Jiang, A. Glassman, R. Krishnan, C.M. O'Connor, and R.M. Califf Depression and ischemic heart disease: what have we learned so far and what must we do in the future? Am Heart J 150 2005 54 78
29. L. Osterberg, and T. Blaschke Adherence to medication New Engl J Med 353 2005 487 497
30. A.J. Claxton, J. Cramer, and C. Pierce A systematic review of the associations between dose regimens and medication compliance Clin Ther 23 2001 1296 1310
31. S.A. Eisen, D.K. Miller, R.S. Woodward, E. Spitznagel, and T.R. Przybeck The effect of prescribed daily dose frequency on patient medication compliance Arch Intern Med 150 1990 1881 1884
32. J.B. Garner Problems of nonadherence in cardiology and proposals to improve outcomes Am J Cardiol 105 2010 1495 1501
33. T.S. Rector, and P.J. Venus Do drug benefits help Medicare beneficiaries afford prescribed drugs? Health Aff (Millwood) 23 2004 213 222
34. N.K. Choudhry, J. Avorn, R.J. Glynn MI FREEE Trial Investigators Full coverage for preventive medications after myocardial infarction New Engl J Med 365 2011 2088 2097
35. N.K. Choudhry, S. Setoguchi, R. Levin, W.C. Winkelmayer, and W.H. Shrank Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients Pharmacoepidemiol Drug Saf 17 2008 1189 1196
36. K.L. Lapane, C.E. Dube, K.L. Schneider, and B.J. Quilliam Misperceptions of patients vs providers regarding medication-related communication issues Am J Manag Care 13 2007 613 618
37. A.I. Goldberg, G. Cohen, and A.H. Rubin Physician assessments of patient compliance with medical treatment Soc Sci Med 47 1998 1873 1876
38. D.M. Tarn, D.A. Paterniti, and R.L. Kravitz How much time does it take to prescribe a new medication? Patient Educ Coun 72 2008 311 319
39. D.M. Tarn, J. Heritage, D.A. Paterniti, R.D. Hays, R.L. Kravitz, and N.S. Wegner Physician communication when prescribing new medications ArchIntern Med 166 2006 1855 1862
40. J.A. Hall, D.L. Roter, and N.R. Katz Meta-analysis of correlates of provider behavior in medical encounters Med Care 26 1988 657 675
41. J.D. Piette, M. Heisler, S. Krein, and E.A. Kerr The role of patient-physician trust in moderating medication nonadherence due to cost pressures Arch Intern Med 165 2005 1749 1755
42. C.A. McHorney The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease Curr Med Res Opin 25 2009 215 238
43. M.R. DiMatteo Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research Med Care 42 2004 200 209
44. D.K. Ziegler, M.C. Mosier, M. Buenaver, and K. Okuyemi How much information about adverse effects of medication do patients want from physicians? Arch Intern Med 161 2001 706 713
45. B.J. Bailey, S.L. Carney, A.H. Gillies, L.M. McColm, A.J. Smith, and M. Taylor Hypertension treatment compliance: what do patients want to know about their medications? Prog Cardiovasc Nurs 12 1997 23 28
46. S.L. Williams, K.B. Haskard, and M.R. DiMatteo The therapeutic effects of the physician-older patient relationship: effective communication with vulnerable older patients Clin Interv Aging 2 2007 453 467
47. B.G. Brown, J. Bardsley, and D. Poulin Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease Am J Cardiol 80 1997 111 115
48. G. Sanz, and V. Fuster Polypill and global cardiovascular health strategies Semin Thorac Cardiovasc Surg 23 2011 24 29
49. G. Glass Cardiovascular combinations Nat Rev Drug Discov 3 2004 731 732
50. S. Yusuf Two decades of progress in preventing vascular disease Lancet 360 2002 2 3
51. K. Teo, S. Lear, S. Islam PURE Investigators Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study JAMA 309 2013 1613 1621
52. S. Bangalore, G. Kamalakkannan, S. Parkar, and F.H. Messerli Fixed-dose combinations improve medication compliance: a meta-analysis Am J Med 120 2007 713 719
53. H.L. Lipton, and J.A. Bird The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: a randomized controlled trial Gerontologist 34 1994 307 315
54. M.L. Bouvy, E.R. Heerdink, J. Urquhart, D.E. Grobbee, A.W. Hoes, and H.G. Leufkens Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study J Card Fail 9 2003 404 411
55. S. Varma, J.C. McElnay, C.M. Hughes, A.P. Passmore, and M. Varma Pharmaceutical care of patients with congestive heart failure: interventions and outcomes Pharmacotherapy 19 1999 860 869